DIFFERENCES IN DRUG-METABOLISM POLYMORPHISM BETWEEN ORIENTALS AND CAUCASIANS

被引：41

作者：

LOU, YC

机构：

[1] Department of Pharmacology, School of Basic Medical Sciences, Beijing Medical University, Beijing

来源：

DRUG METABOLISM REVIEWS | 1990年 / 22卷 / 05期

关键词：

D O I：

10.3109/03602539008991447

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：451 / 475

页数：25

共 103 条

[1]

Agarwal D P, 1986, Prog Clin Biol Res, V214, P99

[2] PHARMACOGENETIC STUDY WITH DIAZEPAM IN TWINS [J].

ALDA, M ;

DVORAKOVA, M ;

POSMUROVA, M ;

BALIKOVA, M ;

ZVOLSKY, P ;

FILIP, V .

NEUROPSYCHOBIOLOGY, 1987, 17 (1-2) :4-8

[3]

ALVAN G, 1982, LANCET, V1, P333

[4] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J].

AYESH, R ;

IDLE, JR ;

RITCHIE, JC ;

CROTHERS, MJ ;

HETZEL, MR .

NATURE, 1984, 312 (5990) :169-170

[5] IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE [J].

BERTILSSON, L ;

HENTHORN, TK ;

SANZ, E ;

TYBRING, G ;

SAWE, J ;

VILLEN, T .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) :348-355

[6]

BOCHNER F, 1983, HDB CLIN PHARM

[7] HUMAN CYTOCHROMES-P-450 [J].

BOOBIS, AR ;

DAVIES, DS .

XENOBIOTICA, 1984, 14 (1-2) :151-185

[8]

BROSEN K, 1985, ACTA PHARMACOL TOX, V57, P357

[9]

BUHLEN R, 1984, ALCOHOLISM, V2, P47

[10]

CHEN R, 2ND INT ISSX M, P111

← 1 2 3 4 5 6 7 8 9 10 →